Watchful waiting for subthreshold depression and anxiety in visually impaired older adults by unknown
Watchful waiting for subthreshold depression and anxiety
in visually impaired older adults
Hilde P. A. van der Aa1,2 • Esther Krijnen-de Bruin1 • Ger H. M. B. van Rens1,2,3 •
Jos W. R. Twisk4 • Ruth M. A. van Nispen1,2
Accepted: 27 May 2015 / Published online: 18 June 2015
 The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract
Purpose Immediate treatment of depression and anxiety
may not always be necessary in resilient patients. This
study aimed to determine remission rates of subthreshold
depression and anxiety, incidence rates of major depressive
and anxiety disorders, and predictors of these remission
and incidence rates in visually impaired older adults after a
three-month ‘watchful waiting’ period.
Methods A pretest–posttest study in 265 visually
impaired older adults (mean age 74 years), from outpatient
low-vision rehabilitation services, with subthreshold
depression and/or anxiety was performed as part of a ran-
domised controlled trial on the cost-effectiveness of a
stepped-care intervention. An ordinal logistic regression
analysis was conducted. Main outcome measures were: (1)
subthreshold depression and anxiety measured with the
Centre for Epidemiologic Studies Depression Scale (CES-
D) and the anxiety subscale of the Hospital Anxiety and
Depression Scale (HADS-A), and (2) depressive and anx-
iety disorders measured with the Mini International Neu-
ropsychiatric Interview.
Results After a three-month watchful waiting period,
depression and anxiety decreased significantly by 3.8
(CES-D) and 1.4 points (HADS-A) (p\ 0.001). Of all
participants, 34 % recovered from subthreshold depression
and/or anxiety and 18 % developed a depressive and/or
anxiety disorder. Female gender [odds ratio (OR) 0.49,
95 % confidence interval (CI) 0.28–0.86], more problems
with adjustment to vision loss at baseline (OR 1.02, 95 %
CI 1.00–1.03), more symptoms of depression and anxiety
at baseline (OR 1.06, 95 % CI 1.02–1.10), and a history of
major depressive, dysthymic, and/or panic disorder (OR
2.28, 95 % CI 1.28–4.07) were associated with lower odds
of remitting from subthreshold depression and/or anxiety
and higher odds of developing a disorder after watchful
waiting.
Conclusions Watchful waiting can be an appropriate step
in managing depression and anxiety in visually impaired
older adults. However, female gender, problems with
adjustment to vision loss, higher depression and anxiety
symptoms, and a history of a depressive or anxiety disorder
confer a disadvantage. Screening tools may be used to
identify patients with these characteristics, who may ben-
efit more from higher intensity treatment or a shorter period
of watchful waiting.
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Abbreviations
RCT Randomised controlled trial
CES-D Centre for Epidemiologic Studies Depression
Scale
HADS-A Hospital Anxiety and Depression Scale—
Anxiety subscale
MINI Mini International Neuropsychiatric Interview
LVQOL Low Vision Quality of Life Questionnaire
AVL Adaptation to Vision Loss Scale
PNCQ Perceived Need for Care Questionnaire
OR Odds ratio
Introduction
Current European and American guidelines in mental
health care recommend a period of ‘active monitoring’ or
‘watchful waiting’ as a first step to deal with mild symp-
toms of depression and anxiety [1–3]. Watchful waiting
involves an active decision of a clinician and patient not to
immediately treat the condition but, instead, to intermit-
tently reassess its status after a certain period of time [4–6].
Watchful waiting may prevent overtreatment and reduce
healthcare costs [4–6]. It is often the first step in a stepped-
care approach, in which subsequent treatment components
are offered by order of intensity [7–10]. It may be an
adequate approach for subthreshold depression and anxiety
(indicating clinically significant symptoms, but no actual
disorder) since the majority of patients in the general
population remits from these conditions without offering
active treatment [5, 11, 12].
However, it is unclear whether watchful waiting would
also suit the vulnerable population of visually impaired
older adults. Vision loss affects about 285 million people
globally, of whom 65 % are aged 50 years or older [13]. It
is one of the leading causes of age-related disability and
can lead to reduced quality of life and higher levels of
depression and anxiety [14–19]. About one-third of visu-
ally impaired older adults experience subthreshold
depression and/or anxiety; 5–7 % are diagnosed with a
major depressive disorder and 7 % with an anxiety disorder
[14–19]. These percentages are substantially higher than
the prevalence in normally sighted peers [14, 20–22]. Both
disorders can have a detrimental impact on visually
impaired older adults, leading to decreased quality of life,
decline in health status, increased vision-specific disability,
and even mortality [16, 23–25]. Because of the high
comorbidity and symptom overlap of depression and anx-
iety in visually impaired older adults, a focus on a com-
bination of these conditions is sensible [14].
In addition, it would be interesting to find out which
factors predict change in depression and anxiety in visually
impaired older adults after watchful waiting to indicate for
which patients this step would be (in)appropriate. Previous
studies indicate that multiple factors may influence
depression and anxiety in visually impaired older adults,
e.g. gender, age [19], perceived vision-specific disability
[26], adaptation to vision loss [27, 28], perceived physical
condition [17, 19, 26, 29], somatic and psychiatric
comorbidities [19, 29], and a history of major depressive
disorder [29]. However, these studies were all cross-
sectional.
The objectives of the present study were to examine: (1)
the remission rate of subthreshold depression and/or anxi-
ety, (2) the incidence of major depressive, dysthymic, and
anxiety disorders, and (3) covariates that predicted remis-
sion and incidence rates in visually impaired older adults
(aged[ 50 years) with subthreshold depression and/or
anxiety after a three-month period of watchful waiting. The
outcomes may offer important information for researchers,
clinicians, and policymakers in the field of low vision to
deal with depression and anxiety.
We hypothesised that demographic variables (gender,
age, education, living situation, income), vision-specific
variables (visual acuity, cause of vision loss, time of onset),
comorbidity, vision-related quality of life, adaptation to
vision loss, symptoms of depression and anxiety, and his-
tory of depressive and anxiety disorders, as measured at
baseline, would be associated with change in the outcome
after watchful waiting. In addition, we took mental health




A pretest–posttest study was conducted among 265 visually
impaired older adults (C50 years) from outpatient low-vi-
sion rehabilitation centres, with subthreshold depression
and/or anxiety. Data were collected from September 2012
to January 2014 as part of a randomised controlled trial
(RCT) to investigate the cost-effectiveness of a stepped-
care programme to prevent depressive and anxiety disor-
ders in visually impaired older adults (trial registration:
http://www.trialregister.nl, identifier: NTR3296) [30].
Unmasked participants were randomised to either the
intervention group (receiving the stepped-care programme
in addition to usual care) or the control group (receiving
usual care only). Data were collected at baseline and after
3 months by means of telephone interviews performed by
masked research assistants who were trained according to a
pre-specified protocol.
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Participants
A total of 3000 patients (aged C 50 years) who were reg-
istered at an outpatient low-vision rehabilitation centre in
the Netherlands or Flanders (the Dutch-speaking part of
Belgium) were invited to participate. Of these, 914 pro-
vided written consent (response rate 30.5 %). In these
patients, eligibility was determined based on: (a) having
subthreshold depression and/or anxiety (a score of C16 on
the Centre for Epidemiologic Studies Depression Scale
(CES-D) [31–33] and/or a score of C8 on the anxiety
subscale of the Hospital Anxiety and Depression Scale
(HADS-A) [34, 35]), (b) not meeting the full diagnostic
criteria for a depressive and/or anxiety disorder (based on
the Mini International Neuropsychiatric Interview (MINI)
[36, 37]), (c) speaking the Dutch language adequately, and
(d) not being severely cognitively impaired (based on the
six-item screener, a short version of the Mini-Mental State
Examination (MMSE) [38]).
Intervention
The first step of the stepped-care programme was a three-
month period of watchful waiting. During this step, the
executive researcher contacted patients by telephone at
baseline and after 3 months (±15 min each), and patient
could contact the executive researcher during this period if
necessary. A three-month period was chosen based on a
previously found effective stepped-care programme in
community-dwelling elderly [10] and on the premise that
all participants received usual care of low-vision rehabili-
tation centres, which could already positively influence the
reduction in depressive and anxiety symptoms [39, 40].
Despite randomisation, both the intervention and control
group received watchful waiting since no actual treatment
was offered. Therefore, the analyses in the present study
were performed on the total group of participants. Never-
theless, randomisation was analysed as a covariate, as the
intervention group was informed about receiving subse-
quent treatment after watchful waiting, which may have
influenced the outcome. Usual care included outpatient
low-vision rehabilitation care and/or care that was provided
by other healthcare providers. The use of mental health
services during watchful waiting was analysed as a
covariate, because this may have influenced the outcome.
Additional details on this RCT and the stepped-care pro-
gramme are described elsewhere [30].
Outcome measures
Subthreshold depression and anxiety
The CES-D and HADS-A were used at baseline and after
3 months to determine subthreshold depression and/or
anxiety. The CES-D is a 20-item questionnaire with total
scores ranging from 0 to 60 and a cut-off score for sub-
threshold depression and/or anxiety of C16 [31]. The CES-
D is considered a valid and reliable instrument to measure
late-life depression and anxiety [32]. However, because the
criterion validity of the CES-D was considerably better for
depression than for anxiety [33], the HADS-A was used to
measure subthreshold anxiety. The HADS-A is a 7-item
subscale which specifically targets anxiety, with scores
ranging from 0 to 21 and a cut-off score for subthreshold
anxiety of C8 [34]. The reliability of the HADS-A is
reported to be good to very good [35].
Major depressive and anxiety disorders
The MINI was used in all participants to determine the
incidence of major depressive, dysthymic, and/or anxiety
disorders (panic disorder, agoraphobia, social phobia, and/
or general anxiety disorder) at baseline and after 3 months
and to determine history of major depressive, dysthymic,
and panic disorder at baseline. This brief diagnostic inter-
view is considered a valid and reliable tool to define mental
disorders according to the DSM-IV based on telephone
interviews in Dutch clinical practice [36, 37].
Vision-related quality of life
The Low Vision Quality of Life Questionnaire (LVQOL)
was used at baseline to measure vision-related quality of
life, with scores ranging from 0 to 100 indicating low to
high quality of life [41, 42]. The LVQOL showed internal
reliability and validity and consists of four subscales: basic
aspects, adjustment, reading and fine work, and mobility
[42, 43]. Adaptation to vision loss was measured at base-
line using the 12-item Adaptation to Vision Loss Scale
(AVL-12). The AVL-12 is a short, efficient measure that
shows strong psychometric properties [44].
Health services utilisation
Utilisation of mental health services was assessed after
3 months of watchful waiting based on the Dutch version
of the Perceived Need for Care Questionnaire (PNCQ)
from the Netherlands Study of Depression and Anxiety
(NESDA) [45]. This is considered a reliable and valid
instrument to distinguish descriptive information of the use
of mental health services [46]. Six types of services were
distinguished: (1) information about mental illnesses and
treatment possibilities; (2) practical support, e.g. vision-
specific tools or domestic help; (3) skills training; (4)
counselling/therapy; (5) medication; and (6) referral to a
mental health services specialist.
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Visual acuity
Decimal visual acuity (based on the internationally used
Snellen chart) was retrieved from the patient files at low-
vision rehabilitation centres at baseline. Missing values
(n = 22) were supplemented with answers that participants
provided themselves based on recent ophthalmic diagnos-
tics. These values were converted into logMAR values
(-log10 visual acuity) in the best eye to enable meaningful
computations. A logMAR visual acuity of 0.00–0.29 indi-
cated normal vision, 0.30–0.51 indicated mild vision loss,
and 0.52–2.00 indicated low vision or blindness.
Comorbidity
Patients were asked about comorbidity at baseline based on
eight large condition groups: asthma or chronic obstructive
pulmonary disease; osteoarthritis and rheumatoid arthritis;
peripheral arterial disease; diabetes mellitus; cardiac dis-
ease; cerebrovascular accident or stroke; cancer; and other
chronic somatic or psychiatric conditions.
Statistical analysis
Paired sample t tests were performed to compare depres-
sion and anxiety scores at baseline and after watchful
waiting. In order to measure predictors of change in
‘severity of depression and anxiety’, first the outcome
variable was categorised into three groups: (1) no symp-
toms of depression and/or anxiety (CES-D score of \16
and HADS-A score of \8), (2) subthreshold depression
and/or anxiety (CES-D score of C16 and/or HADS-A score
of C8), and (3) major depressive, dysthymic, and/or anxi-
ety disorder (measured with the MINI). Therefore, patients
with a diagnosis of a disorder (based on the MINI) were
categorised into the last group, despite their scores on the
CES-D and HADS-A. This categorisation is also used in
the RCT to investigate the cost-effectiveness of the total
stepped-care programme to determine whether patients
should move on to a higher intensity treatment component
[30].
Second, a stepwise ordinal logistic regression analysis
was performed (p B 0.10) with the following covariates
measured at baseline: gender, age, education, living situa-
tion, income, visual acuity, cause of vision loss, time of
onset of the visual impairment, comorbidity, vision-related
quality of life, adaptation to vision loss, baseline CES-D
scores, baseline HADS-A scores, history of major depres-
sive, dysthymic, and/or panic disorder, and randomisation
status. Mental health services utilisation measured after
3 months was also taken into account. In addition, we
checked for interaction effects of age, education, and living
situation. Education was recoded into the number of years
having received education. Living situation (dependent or
independent), cause of vision loss (macular degeneration or
other), comorbidity (having a comorbid disorder or not),
and mental health services utilisation (having received
some form of mental health services or not) were dichot-
omised. Proportionality of odds ratios (ORs) were tested
with the logit link function, multicollinearity was tested
with a variance inflation factor (VIF) of\3, and linearity
was tested by means of dummy variables. Data analysis
was performed using SPSS 20.
Results
Demographic and clinical characteristics
No significant difference was found in gender between
responders and non-responders; however, responders were
significantly younger than non-responders (mean differ-
ence = 4.6 years, p\ 0.001). Loss to follow-up after
3 months of watchful waiting was 9.3 %. No significant
difference was found between participants who dropped
out and those who did not drop out in any of the relevant
outcome measures. The most common reasons for partic-
ipants to drop out of the study were: (1) mortality and (2) it
was too great a burden to continue. Table 1 shows that the
average age of the study population at baseline was
74 years; the majority of participants was female (69.8 %)
and lived independently (90.2 %). Almost half of the par-
ticipants had macular degeneration, and the mean time of
onset was 15.2 years ago. About 21 % had a history of
major depressive disorder, about 2 % had a history of
dysthymic disorder, and about 6 % had a history of panic
disorder. During watchful waiting, more than half of the
study population received some form of mental health
services. Practical support (35.0 %), information about
mental illnesses and treatment possibilities (18.3 %),
counselling/therapy (17.1 %), and medication (17.1 %)
were received most often. These services were mostly
provided by social workers and psychologists.
Remission rates
Table 1 shows that after 3 months, 34.1 % remitted from
subthreshold depression and/or anxiety, 47.6 % still expe-
rienced subthreshold depression and/or anxiety, and
18.3 % had progressed to a major depressive, dysthymic,
and/or anxiety disorder. In the latter group, 11.4 % had
developed an anxiety disorder, 10.2 % had developed a
depressive disorder, and 3.3 % had developed both a
depressive and anxiety disorder. Table 2 shows that there
was a significant reduction in depressive and anxiety
symptoms after 3 months of watchful waiting. The total
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Table 1 Patient characteristics
at baseline (N = 265) and after
watchful waiting (N = 246)
Total
Measured at baseline (N = 265)
Gender (female) [N (%)] 185 (69.8 %)
Age (years), range [50–98] (mean (SD), median) 73.7 (12.3), 75.0
Education (years), range [0–16] (mean (SD), median)a 9.8 (3.6), 10.0
Living situation (independent) [N (%)] 239 (90.2 %)
Income [N (%)]b
Usually enough money 123 (46.4 %)
Just enough money 112 (42.3 %)
Not enough money 25 (9.4 %)
LogMAR visual acuity [N (%)]c
Normal visual acuity 24 (9.1 %)
Mild vision loss 47 (17.7 %)
Low vision or blindness 172 (64.9 %)
Cause of vision loss [N (%)]d
Macular degeneration 122 (46.0 %)
Glaucoma 45 (17.0 %)
Cataract 45 (17.0 %)
Cerebral haemorrhage 15 (5.7 %)
Diabetic retinopathy 9 (3.4 %)
Other 105 (39.6 %)
Time of onset of the visual impairment (years), range [0–79] (mean (SD), median)e 15.2 (18.9), 8.0
Having one or more comorbid disorder [N (%)] 154 (62.6 %)
Adaptation to vision loss, range [16–48] (mean (SD))f 31.5 (6.1)
Vision-specific quality of life, range [0–180] [mean (SD)]
Basic aspectsg 54.8 (17.1)
Adjustmenth 40.4 (20.0)
Reading and fine workg 50.6 (25.4)
Mobilityi 51.2 (21.0)
History of major depressive disorder [N (%)] 55 (20.8 %)
History of dysthymic disorder [N (%)] 5 (1.9 %)
History of panic disorder [N (%)] 17 (6.4 %)
Measured after watchful waiting (N = 246)
Mental health services utilisation [N (%)]
Information 45 (18.3 %)
Practical support 86 (35.0 %)
Counselling/therapy 42 (17.1 %)
Medication 42 (17.1 %)
Referral to specialist 15 (6.1 %)
Skills training 9 (3.7 %)
None 118 (44.4 %)
Severity of depression and anxiety [N (%)]
No symptoms 84 (34.1 %)
Subthreshold symptoms 117 (47.6 %)
Depressive/anxiety disorder 45 (18.3 %)
Range, means and standard deviations (SD) are reported for continuous variables, and the median is
additionally provided when the variable has an asymmetric distribution. Missing observations (N:)
a21;b5;c22;d2;e4;f18;g23;h14; i20
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CES-D score dropped 3.8 points (p\ 0.001), while the
total HADS-A score dropped 1.4 points (p\ 0.001).
Plausible predictors of improvement
No plausible multicollinearity was found, and the propor-
tionality of ORs was met. Age and time of onset of the
visual impairment had no linear relationship with the out-
come measure. Therefore, the scales of these variables
were changed into an ordinal scale with four equally large
categories (quartiles). In addition, we found no interaction
effects of age, education, and living situation (p[ 0.05).
All hypothesised covariates were included in the model
(Table 3; full model). After conducting the backward-
stepwise procedure, gender, the baseline CES-D scores, the
baseline scores on the adjustment subscale of the LVQOL,
history of major depressive, dysthymic, and/or panic dis-
order proved to be significant predictors (p B 0.10) of
severity of depression and anxiety after 3 months (Table 3;
final model). The final model explained 10.4 % (Cox and
Snell R square) to 11.9 % (Nagelkerke R squared) of the
variance in severity of depression and anxiety.
The model indicated that female gender [odds ratio (OR)
0.49, 95 % confidence interval (CI) 0.28–0.86], more
symptoms of depression and anxiety at baseline (OR 1.06,
95 % CI 1.02–1.10), more problems with adjustment to
vision loss at baseline (OR 1.02, 95 % CI 1.00–1.03), and a
history of major depressive, dysthymic, and/or panic dis-
order (OR 2.28, 95 % CI 1.28–4.07) were associated with
higher odds of developing a major depressive, dysthymic,
and/or anxiety disorder and lower odds of remitting from
subthreshold depression and/or anxiety after watchful
waiting. Randomisation did not appear to be a predictor,
confirming that it was appropriate to perform analysis on
the total group of participants.
Discussion
The present study indicates that watchful waiting can be an
appropriate first step for visually impaired older adults with
mild symptoms of depression and/or anxiety. During this
period, one in three participants recovered from sub-
threshold depression and/or anxiety. Community-based
surveys suggest remission rates in more than half of the
cases [11, 12]. Our percentage is lower, but can be
expected because our population is less resilient based on a
higher age and visual impairment. Hegel et al. [5] reported
substantially lower remission rates of 9–13 % in primary
care patients after a follow-up period of one month. This
difference may be explained by the shorter time period
chosen by Hegel et al. [5] and the low percentage of eli-
gible participants that enrolled and remained in their study
throughout the watchful waiting period.
In contrast, a reasonably high percentage (18 %) of our
study population developed a major depressive, dysthymic,
and/or anxiety disorder during watchful waiting. Female
patients with more symptoms of depression and/or anxiety,
more problems with adjustment to vision loss, and a history
of major depressive, dysthymic, and/or panic disorder had
higher odds of developing a disorder during watchful
waiting, which is in line with previous studies [27–29]. For
these patients, watchful waiting may not be an appropriate
step. They may benefit more from a higher intensity
treatment or a shorter period of watchful waiting with more
frequent monitoring. Current guidelines of the National
Institute for Health and Care Excellence (NICE) in the UK
recommend using a watchful waiting period of 2 weeks,
which may be more appropriate [2].
Screening questionnaires may be used to identify
patients that are less resilient in overcoming subthreshold
depression and anxiety. A brief version of the Patient
Health Questionnaire (PHQ), which can be used by non-
mental health staff to screen for depression and anxiety,
may be suitable for this purpose [47, 48]. When patients
experience depression and/or anxiety based on this short
screener, extensive questionnaires can be used to determine
whether watchful waiting is appropriate, in which history
of depressive and anxiety disorders should be taken into
account.
Strengths and limitations
The present study has several strengths. It is the first study
to investigate watchful waiting in visually impaired older
adults, and only a few other studies have investigated
watchful waiting in the general population [5, 11, 12].
Therefore, the outcomes may be meaningful for both
Table 2 Depression and
anxiety symptoms at baseline
and after watchful waiting
Patient characteristics Baseline After watchful waiting t p
CES-D [mean (SD)] 21.3 (6.4) 17.5 (8.7) 6.048 <0.001
HADS-A [mean (SD)] 7.1 (4.0) 5.7 (3.8) 4.900 <0.001
Bold is significant at p\ 0.05
CES-D Centre for Epidemiologic Studies Depression Scale, HADS-A Hospital Anxiety and Depression
Scale—Anxiety subscale
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research and clinical practice. It may offer important
indications for clinicians and policymakers to deal with
depression and anxiety in the field of low vision. In addi-
tion, validated questionnaires were used to analyse symp-
toms of depression and anxiety as well as actual disorders
according to the DSM-IV, enabling to examine remission
rates of depression and anxiety as well as incidence rates of
actual disorders.
However, this study also has some limitations. Only
treatment-seeking patients (i.e. outpatient low-vision
rehabilitation services), who enrolled in a randomised
controlled study, were included in the present study. Only
30.5 % of the invited patients provided written informed
consent, and these responders were significantly younger
than non-responders. In addition, study participants may
have been relatively healthier (i.e. able to take part in the
interviews and not cognitively impaired) and may have had
higher needs for and better access to health services. This
reduces generalisability of the outcomes.
Furthermore, it should be noted that more than half of
the participants received some form of mental health ser-
vices during watchful waiting, as they were all in care of
Table 3 Univariate and multivariate determinants of severity of depression and anxiety (higher category refers to greater severity) after watchful
waiting based on an ordinal logistic regression analysis using a backwards stepwise procedure (N = 246)
Predictors Univariate Multivariate (full model) Multivariate (end model)
OR 95 % CI p OR 95 % CI p OR 95 % CI p
Gender (male vs. female) 0.64 0.39–1.08 0.092 0.69 0.33–1.45 0.327 0.49 0.28–0.86 0.013
Age (years)a
50–62 0.88 0.46–1.69 0.698 0.34 0.10–1.11 0.958
63–75 0.96 0.50–1.85 0.900 0.62 0.22–1.71 0.357
76–83 0.61 0.31–1.21 0.159 0.74 0.28–1.96 0.548
Education (years) 0.98 0.91–1.05 0.495 0.94 0.85–1.04 0.231
Living situation (independent vs. dependent) 0.63 0.25–1.60 0.336 1.58 0.25–9.81 0.626
Incomeb
Usually enough money 0.50 0.21–1.16 0.108 1.03 0.29–3.65 0.958
Just enough 0.48 0.20–1.13 0.092 0.29 0.25–2.94 0.801
Visual acuityc
Normal vision 1.23 0.54–2.78 0.624 0.96 0.29–3.21 0.941
Mild vision loss 1.08 0.58–2.03 0.805 0.78 0.33–1.85 0.573
Cause of vision loss (macular degeneration vs. other) 1.46 0.91–2.34 0.117 1.27 0.60–2.69 0.531
Time of onset of the VI (years)d
0–3 1.44 0.75–2.77 0.270 1.46 0.52–4.09 0.475
4–7 1.60 0.78–3.25 0.200 1.38 0.47–4.07 0.562
8–18 1.69 0.87–3.27 0.120 0.99 0.35–2.80 0.975
Having one or more comorbid disorders versus none 1.28 0.78–2.08 0.326 1.54 0.78–3.06 0.215
CES-D score 1.05 1.02–1.10 0.007 1.04 0.99–1.10 0.088 1.06 1.02 –1.10 0.006
HADS-A score 1.09 1.03–1.16 0.005 1.06 0.97–1.10 0.173
Having a history of depressive/dysthymic/panic disorder
versus no history
1.88 1.10–3.21 0.021 1.94 0.90–4.20 0.093 2.28 1.28–4.07 0.005
LVQOL: basic aspects 1.02 1.00–1.03 0.051 1.03 1.01–1.06 0.016
LVQOL: adjustment 1.02 1.01–1.03 0.007 1.02 1.00–1.05 0.048 1.02 1.00–1.03 0.031
LVQOL: reading and fine work 1.01 0.99–1.02 0.216 0.99 0.97–1.01 0.154
LVQOL: mobility 1.02 1.00–1.03 0.013 1.00 0.98–1.02 0.715
Adaptation to vision loss 1.02 0.98–1.06 0.277 0.92 0.86–0.99 0.018
Having used one or more mental healthcare services versus
none
1.42 0.89–2.28 0.145 1.64 0.83–3.24 0.159
Randomisation (control group vs. intervention group) 1.14 0.71–1.83 0.580 0.70 0.36–1.37 0.301
Positive estimates indicate a higher category of the outcome compared to the reference
Reference group: a, age 84–98, b, not enough money; c, low vision/blindness; d, 19–79 years ago
CES-D Centre for Epidemiologic Studies Depression Scale, HADS-A Hospital Anxiety and Depression Scale—Anxiety subscale, LVQOL Low
Vision Quality of Life Questionnaire
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outpatient low-vision rehabilitation centres and were free
to seek help elsewhere if they wanted to. This may have
undermined the actual goal of watchful waiting, i.e. not
receiving professional mental health services. However,
received mental health services did not prove to be a sig-
nificant predictor of the outcome measure. In addition, the
final model only explained 10.4–11.9 % of the variance in
severity of depression and anxiety. Further research is
needed to investigate other constructs (e.g. social support,
family history of depression) that may influence the
outcome.
Conclusion
Watchful waiting appears to be an effective first step in
dealing with subthreshold depression and anxiety in visu-
ally impaired older adults. However, female gender,
problems with adjusting to vision loss, higher depression
and anxiety symptoms, and a history of major depressive,
dysthymic, and/or panic disorder confer a disadvantage.
Short screening tools may be used to identify patients for
whom watchful waiting may be less appropriate. These
patients may benefit more from a higher intensity treatment
or a shorter period of watchful waiting. Since evidence for
watchful waiting is limited, future studies are needed to
confirm our findings and to determine the most appropriate
time period for different patient groups.
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